Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005-2016
Our recent RWE study detailed the comorbidity burden of Finnish multiple myeloma (MM) patients diagnosed between 2005 and 2016.
News
-
-
Text mining helped analyse a million entries on smoking
How to review and analyse a million sentences? Text mining decreased the work of clinical experts and accelerated the research process.
-
Heini Honkanen appointed as Medaffcon’s Market Access Lead
Heini Honkanen has been appointed as Medaffcon’s Market Access Lead. The new Market Access Team was created when the previous Price and Reimbursement and HE & Access Teams were merged.
-
Unstructured healthcare data contributes to solving new issues
Finland has unique data for pharmaceutical purposes and unstructured healthcare data can also be already effectively utilised.
-
Greetings from ISPOR: the use of Real World Evidence is becoming more common
Medaffconin Tanja Nieminen ja Heini Honkanen osallistuivat terveystaloustieteen tutkimukseen ja terveydenhuollon menetelmien arviointiin keskittyvään ISPOR-kongressiin marraskuussa.
-
“We always provide the customer with a solution to their problem”
CEO Jarmo Hahl explains what Medaffcon’s service entity consists of and what makes Medaffcon an excellent partner for their customers.
-
Virtual control groups in pharmaceutical development – What are they and can they be trusted?
Single-arm research designs are challenging for a pharmaceutical reimbursement and marketing authorisation process.
-
Findata reformed the processing of data permit applications – customers benefit in a diversity of manners
Finnish Social and Health Data Permit Authority Findata has significantly reformed and accelerated the processing...
-
Need for medicine-related data increases, the system responds to the change slowly
It would be useful to have RWE support the decision-making related to managed introduction and...
-
RWE complements the overall picture of the authorities
In health economic studies, real world evidence (RWE) can produce additional knowledge, especially on the...
-
A clinician’s perspective: The reimbursement of a medicine impacts the selected treatment
The basic reimbursement granted for medicinal substance teduglutide was a significant step forward for children...
-
Gaucher study provides new aspects in rare disease screening and the utilization of data and specimens of the Finnish biobanks
The study assessed the prevalence of Gaucher disease in Finland and developed methods to screen...
-
Real world evidence supports the market access of medicines – teduglutide as an example
We already have clinical medicine trials. Why on earth do we also need real world...
-
Cardiovascular outcome according to renal status in Finnish patients with type 2 diabetes
Chronic kidney disease has been suggested as the main contributor to the increased cardiovascular morbidity...
-
Medicines data repository would decrease overlapping work
Planning of a medicines data repository compiling different data sets is well underway, which is...
-
Synthetic data and a common data register – the future of real-world evidence is fast approaching
Utilisation of real-world evidence (RWE) progresses at speed and development steps are fast. Utilising real-world...
-
Studies that utilise real-world evidence consolidate relations with clinicians
Studies relying on real-world evidence help clinicians to create a better overall picture of the...
-
Pioneers already utilise real-world evidence actively
The results of studies based on real-world data (RWD) have convinced also people that were...
-
Real-world evidence completes clinical trials – the significance of data may increase in the future
RWE or real-world evidence provides authorities assessing pharmacotherapies with data on the prevalence of a...
-
Medical authority values the consistency of health economic evaluations
Health economic evaluations bring additional information to the authorities’ decision-making concerning medicinal products. How does...
-
Uncertainty is always present when assessing the introduction of a new medicine
From the perspective of decision-making, it is important that a health economic evaluation conducted on...
-
Patients with atherosclerotic cardiovascular disease are at high risk of death after the first cardiovascular event, shows a Finnish real-world evidence study
Cardiovascular diseases are the leading cause of disability and premature death worldwide. Real-world evidence (RWE)...
-
National price negotiation of hospital-only medicinal products is not an auction
HUS Pharmacy Director Kerstin Carlsson reveals the process of national price negotiation of hospital-only medicinal...
-
Utilisation of Finnish hospital data lake data to analyse diffuse large B-cell lymphoma (DLBCL) in a real-world setting: Recording practices at routine care should be developed
Real-world data on diffuse large B-cell lymphoma (DLBCL) has remained incomplete. In Finland, electronic health...
-
Medaffcon welcomes Omicron and Value Coaching into the cooperation network
Medaffcon expands its network of companies to Omicron ApS and Value Coaching Oy to extend...
-
Hip and knee osteoarthritis more than doubles the number of sick leave days and occupational healthcare contacts for working age individuals
Research has shown that osteoarthritis causes disability, especially among older adults. Our latest real-world evidence...
-
LINK Medical and Medaffcon join forces in Real World Evidence (RWE) and Market Access to offer customers full support across the Nordics
OSLO, Norway/ ESPOO, Finland May 24, 2021 LINK Medical, the Northern European clinical research organization...
-
DLIMI and Medaffcon join forces to enhance Nordic Real World Evidence (RWE) studies
DLIMI and Medaffcon join forces to provide research-based pharmaceutical companies with Nordic Real World Evidence...
-
Characteristics and survival trends in Finnish multiple myeloma patients—a nationwide real-world evidence study
Multiple myeloma (MM) is a hematologic cancer displaying an abnormal heterogenous B cell population in...
-
Prototype of a Gaucher disease point-scoring system successfully tested in Finnish patients
A prototype of a Gaucher disease point-scoring system (PSS), originally established by the Gaucher Earlier...
-
New RWE themed blog to start in March!
Interested in RWE research? Health from data is the first real-world evidence themed blog written...
-
Finnish ecosystem supports the use of real world evidence (RWE)
Real World Evidence (RWE) ecosystem in Finland Real world data (RWD) is defined by FDA...
-
Pharmaceutical Pricing and Market Access of Medicine products in Finland
Medicines in Finland are divided into medicines in ambulatory and hospital care. This article describes...
-
My Migraine Voice -survey reveals the emotional and social burden of migraine in Finland
Migraine is a disabling headache disorder that places a significant burden both for the patients...
-
Navigating the Real World Data (RWD) landscape in Finland
The real world data (RWD) landscape in Finland offers globally unique data and possibilities to...
-
Specific patient characteristics of heart failure across the LVEF range highlight the importance of effective treatments to reduce hospitalizations
The proportion of patients hospitalized for heart failure (HF) with preserved left ventricular ejection fraction...
-
Multimorbidity across multiple ICD-10 codes should be considered when treating migraine patients
In migraine, co-occurrence of two or more diseases or conditions is typical. Asthma and allergies,...
-
The Burden of Idiopathic Pulmonary Fibrosis (IPF) in Finland
A new real world evidence study on Idiopathic pulmonary fibrosis (IPF) describes the high disease...
-
The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization
Chronic obstructive pulmonary disease is one of the leading causes of mortality and morbidity worldwide....
-
Machine learning based tools in the analysis of RWD; focus on image recognition
Healthcare provides various types of Real World Data (RWD) that can be used to generate...
-
Migraine comorbidity and phenotypic disease networks in occupational health care
The Burden of Migraine Study continues The study ‘Migraine comorbidity and phenotypic disease networks in...
-
The burden of adult asthma in Finland: impact of disease severity and eosinophil count on health care resource utilization
Medaffcon’s new real-world evidence study on the burden of adult asthma in Finland demonstrates the...
-
HIMSS & Health 2.0 European Conference
HIMSS & Health 2.0 European conference took place on 11-13.6.2019 in Helsinki. 3 000 professionals...
-
Heart failure in Finland: clinical characteristics, mortality, and healthcare resource use
The high mortality rate of heart failure (HF) patients compared to age-matched controls highlights the...
-
Migraine nearly doubles the amount of healthcare visits and sick-leave days
New real-world evidence (RWE) based study shows that migraine nearly doubles the amount of healthcare...